|
Originally published In Press as doi:10.1074/jbc.M211579200 on January 6, 2003
J. Biol. Chem., Vol. 278, Issue 11, 9283-9289, March 14, 2003
Functional Activity of the Complement Regulator Encoded by
Kaposi's Sarcoma-associated Herpesvirus*
O. Brad
Spiller §,
David J.
Blackbourn¶,
Linda
Mark ,
David G.
Proctor , and
Anna M.
Blom **
From the University of Wales College of Medicine,
Virus Receptor and Immune Evasion Group, Department of Medical
Biochemistry, Heath Park, Cardiff CF14 4XX, United Kingdom, the
¶ Division of Virology, Institute of Biomedical and Life Sciences,
University of Glasgow, Church Street, Glasgow G11 5JR, United Kingdom,
and the Department of Clinical Chemistry, Lund University,
University Hospital Malmö, Malmö S-205 02 Sweden
Kaposi's sarcoma-associated herpesvirus (KSHV)
is closely associated with Kaposi's sarcoma and certain B-cell
lymphomas. The fourth open reading frame of the KSHV genome encodes a
protein (KSHV complement control protein (KCP, previously termed ORF4)) predicted to have complement-regulating activity. Here, we show that
soluble KCP strongly enhanced the decay of classical C3-convertase but
not the alternative pathway C3-convertase, when compared with the host
complement regulators: factor H, C4b-binding protein, and
decay-accelerating factor. The equilibrium affinity constant (KD) of KCP for C3b and C4b was determined by
surface plasmon resonance analysis to range between 0.47-10
µM and 0.025-6.1 µM, respectively,
depending on NaCl concentration and cation presence. Soluble and
cell-associated KCP acted as a cofactor for factor I (FI)-mediated
cleavage of both C4b and C3b and induced the cleavage products C4d and
iC3b, respectively. In the presence of KCP, FI further cleaved iC3b to
C3d, which has never been described before as complement receptor 1 only mediates the production of C3dg by FI. KCP would enhance virus
pathogenesis through evading complement attack, opsonization, and
anaphylaxis but may also aid in targeting KSHV to one of its host
reservoirs since C3d is a ligand for complement receptor 2 on
B-cells.
*
This study was supported by grants from the Swedish Research
Council (to A. B.), Kock's Trust, Österlunds Trust, Crafoord Trust, Royal Physiographic Society in Lund, Groschinsky's Trust, King
Gustav V's 80th Anniversary Foundation, Zoega's Trust, and University
Hospital in Malmö. This study was also supported by the Wellcome
Trust Foundation, Cancer Research UK (to O. B. S. and D. J. B.)
Grant C7934 and the Association for International Cancer Research Grant
01-242 (to D. J. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Wellcome Trust Career Development Fellow.
**
To whom correspondence should be addressed. Tel.: 46-40-33-82-33;
Fax: 46-40-33-70-44; E-mail: Anna.Blom@klkemi.mas.lu.se.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Okroj, L. Mark, A. Stokowska, S. W. Wong, N. Rose, D. J. Blackbourn, B. O. Villoutreix, O. B. Spiller, and A. M. Blom
Characterization of the Complement Inhibitory Function of Rhesus Rhadinovirus Complement Control Protein (RCP)
J. Biol. Chem.,
January 2, 2009;
284(1):
505 - 514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Mark, O. B. Spiller, M. Okroj, S. Chanas, J. A. Aitken, S. W. Wong, B. Damania, A. M. Blom, and D. J. Blackbourn
Molecular Characterization of the Rhesus Rhadinovirus (RRV) ORF4 Gene and the RRV Complement Control Protein It Encodes
J. Virol.,
April 15, 2007;
81(8):
4166 - 4176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Singh, J. Mullick, J. Bernet, and A. Sahu
Functional Characterization of the Complement Control Protein Homolog of Herpesvirus Saimiri: ARG-118 IS CRITICAL FOR FACTOR I COFACTOR ACTIVITIES
J. Biol. Chem.,
August 11, 2006;
281(32):
23119 - 23128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. R. Rezaee, C. Cunningham, A. J. Davison, and D. J. Blackbourn
Kaposi's sarcoma-associated herpesvirus immune modulation: an overview
J. Gen. Virol.,
July 1, 2006;
87(7):
1781 - 1804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. B. Spiller, L. Mark, C. E. Blue, D. G. Proctor, J. A. Aitken, A. M. Blom, and D. J. Blackbourn
Dissecting the Regions of Virion-Associated Kaposi's Sarcoma-Associated Herpesvirus Complement Control Protein Required for Complement Regulation and Cell Binding.
J. Virol.,
April 1, 2006;
80(8):
4068 - 4078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. O'Connor and D. H. Kedes
Mass Spectrometric Analyses of Purified Rhesus Monkey Rhadinovirus Reveal 33 Virion-Associated Proteins
J. Virol.,
February 1, 2006;
80(3):
1574 - 1583.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Mullick, J. Bernet, Y. Panse, S. Hallihosur, A. K. Singh, and A. Sahu
Identification of Complement Regulatory Domains in Vaccinia Virus Complement Control Protein
J. Virol.,
October 1, 2005;
79(19):
12382 - 12393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. G. Goodfellow, D. J. Evans, A. M. Blom, D. Kerrigan, J. S. Miners, B. P. Morgan, and O. B. Spiller
Inhibition of Coxsackie B Virus Infection by Soluble Forms of Its Receptors: Binding Affinities, Altered Particle Formation, and Competition with Cellular Receptors
J. Virol.,
September 15, 2005;
79(18):
12016 - 12024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Mullick, A. K. Singh, Y. Panse, V. Yadav, J. Bernet, and A. Sahu
Identification of Functional Domains in Kaposica, the Complement Control Protein Homolog of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8)
J. Virol.,
May 1, 2005;
79(9):
5850 - 5856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Sfyroera, M. Katragadda, D. Morikis, S. N. Isaacs, and J. D. Lambris
Electrostatic Modeling Predicts the Activities of Orthopoxvirus Complement Control Proteins
J. Immunol.,
February 15, 2005;
174(4):
2143 - 2151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Mark, W. H. Lee, O. B. Spiller, D. Proctor, D. J. Blackbourn, B. O. Villoutreix, and A. M. Blom
The Kaposi's Sarcoma-associated Herpesvirus Complement Control Protein Mimics Human Molecular Mechanisms for Inhibition of the Complement System
J. Biol. Chem.,
October 22, 2004;
279(43):
45093 - 45101.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|